Cargando…
Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis
Information on the efficacy of pegylated interferon (PEG-IFN) treatment of chronic hepatitis B (CHB) patients and predictors of the response based on real-world data is limited. Consecutive 201 patients who underwent PEG-IFN treatment for CHB were reviewed. A virological response (VR) was defined as...
Autores principales: | Wang, Yin-Chen, Yang, Sien-Sing, Su, Chien-Wei, Wang, Yuan-Jen, Lee, Kuei-Chuan, Huo, Teh-Ia, Lin, Han-Chieh, Huang, Yi-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941731/ https://www.ncbi.nlm.nih.gov/pubmed/27405043 http://dx.doi.org/10.1038/srep29605 |
Ejemplares similares
-
CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study
por: Lee, I-Cheng, et al.
Publicado: (2013) -
Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World
por: Sun, Yingxin, et al.
Publicado: (2021) -
Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021) -
Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism
por: Ekstrom, Victoria, et al.
Publicado: (2017) -
Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)